These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Malaria vaccines. Are they approaching reality? Perlmann P Nature; 1987 Jul 16-22; 328(6127):205-6. PubMed ID: 3299105 [No Abstract] [Full Text] [Related]
10. Towards a malaria vaccine: what is in sight? del Giudice G Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171 [No Abstract] [Full Text] [Related]
11. [NANP]19-5.1. A malaria vaccine field trial in Nigerian children. Reber-Liske R; Salako LA; Matile H; Sowunmi A; Stürchler D Trop Geogr Med; 1995; 47(2):61-3. PubMed ID: 8592764 [TBL] [Abstract][Full Text] [Related]
12. Malaria vaccine development using synthetic peptides as a technical platform. Corradin G; Céspedes N; Verdini A; Kajava AV; Arévalo-Herrera M; Herrera S Adv Immunol; 2012; 114():107-49. PubMed ID: 22449780 [TBL] [Abstract][Full Text] [Related]
13. The case for a subunit vaccine against malaria. Anders RF Trends Parasitol; 2011 Aug; 27(8):330-4. PubMed ID: 21592861 [TBL] [Abstract][Full Text] [Related]
14. The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines. Del Giudice G; Cooper JA; Merino J; Verdini AS; Pessi A; Togna AR; Engers HD; Corradin G; Lambert PH J Immunol; 1986 Nov; 137(9):2952-5. PubMed ID: 3531341 [TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Herrington DA; Clyde DF; Losonsky G; Cortesia M; Murphy JR; Davis J; Baqar S; Felix AM; Heimer EP; Gillessen D Nature; 1987 Jul 16-22; 328(6127):257-9. PubMed ID: 2439920 [TBL] [Abstract][Full Text] [Related]
18. Proteosome-hydrophobic 'foot' malaria peptide vaccines for Plasmodium falciparum and P. vivax. Lowell GH; Ballou WR; Smith LF; Zollinger WD; Hockmeyer WT Trans R Soc Trop Med Hyg; 1989; 83 Suppl():101-2. PubMed ID: 2696152 [TBL] [Abstract][Full Text] [Related]
19. Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens. Quakyi IA; Otoo LN; Pombo D; Sugars LY; Menon A; De Groot AS; Johnson A; Alling D; Miller LH; Good MF Am J Trop Med Hyg; 1989 Aug; 41(2):125-34. PubMed ID: 2672834 [TBL] [Abstract][Full Text] [Related]
20. Potentiation of cell-mediated immune responses directed against P. falciparum sporozoite peptide vaccine by immunomodulators. Russo DM; Sundy JS; Maguire HC; Weidanz WP Adv Exp Med Biol; 1989; 251():203-7. PubMed ID: 2692427 [No Abstract] [Full Text] [Related] [Next] [New Search]